|
|
BVM Capital, formerly known as Barrett, Vernon, Montgomery, is a Southeast-based venture capital firm that provides equity capital to early and expansion stage companies with proprietary technology platforms or unique products addressing large markets. The partners of BVM Capital manage two investment funds: Louisiana Ventures, LP and TVP (Themelios Venture Partners). Louisiana Ventures is a generalist fund as far as industry preference, and invests opportunistically in high growth equity opportunities. In contrast, TVP is focused on life science opportunities from the Pennington Biomedical Research Center, the world's leader in diabetes, nutrition and obesity research. TVP will also invest in companies outside of the Pennington Center that run clinical trials or conduct research collaborations with the Center, thus, diversifying TVP's investment mix. BVM Capital's initial investments in portfolio companies typically range from $100,000 to $500,000 with up to $3 million in total capital allocated for follow-on rounds in any one opportunity. Each portfolio company must be projected to be generating at least $50 million in annualized revenue within 5 years and or have an enterprise valuation in excess of $100 million.
|
